Gene · 9563
NIH grants918
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 918
Download this page as JSON| Grant | Title | H6PD papers | Newest fiscal year |
|---|---|---|---|
| P60AA010760 | Behavioral Genomics of Alcohol Neuroadaptation | 1 | 2025 |
| R01AI114581 | Dissect and target Arginine-polyamine metabolic axis in T cell mediated inflammation and autoimmunity | 1 | 2025 |
| R01AI141894 | Cellular mechanisms by which Neisseria gonorrhoeae infects the female reproductive tract | 1 | 2025 |
| R01AI172873 | Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS | 1 | 2025 |
| R01CA090764 | PI3K/PTEN/Akt signaling and the genesis of cancer | 1 | 2025 |
| R01CA140515 | Signaling importance of ‘functionless’ lyso-PAF, an inactive form of platelet activating factor, in melanoma with mutant Nras | 1 | 2025 |
| R01CA172382 | Elucidating a novel molecular biomarker for castration-resistant prostate cancer | 1 | 2025 |
| R01CA193842 | Characterizing the MSI2 network in leukemia | 1 | 2025 |
| R01CA241623 | The Role of Genetic Risk Factors in Keratinocyte Carcinoma Susceptibility | 1 | 2025 |
| R01CA272855 | Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoids | 1 | 2025 |
| R01CA278051 | Label-free imaging of CAR T cell metabolism | 1 | 2025 |
| R01DE017102 | TRPC1, Calcium, and Saliva Secretion | 1 | 2025 |
| R01DK024092 | SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis | 1 | 2025 |
| R01DK046492 | Engineered Glucose Metabolism in Insulin Secreting Cells | 1 | 2025 |
| R01DK064819 | Mechanisms of Beta Cell Failure | 1 | 2025 |
| R01DK075787 | Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum | 1 | 2025 |
| R01DK078081 | Metabolic crosstalks in regulation of beta-cell stress response and adaptation | 1 | 2025 |
| R01DK084171 | CTRP and Metabolic Control | 1 | 2025 |
| R01DK093757 | Genetic epidemiology of rare and regulatory variants for metabolic traits | 1 | 2025 |
| R01DK107667 | Selective mTORC1 inhibition to prevent and treat NAFLD and NASH | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9563/grants?page=5